Improvement of dyslipidemia in patients switching from stavudine to tenofovir-Reference-Cited by-同舟云学术

Improvement of dyslipidemia in patients switching from stavudine to tenofovir

Published:2004-07-02 Issue:10 Volume:18 Page:1475-1478
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Domingo Pere,Labarga Pablo,Palacios Rosario,Guerrero Manuel Fernández,Terrón José Alberto,Elías María JPérez,Santos Jesús,Camps María IRuiz,Llibre Josep M,Moreno Santigo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference11 articles.

1. Adverse effects of antiretroviral therapy.;Carr;Lancet,2000

2. Metabolic and anthropometric consequences of interruption of highly active antiretroviral therapy.;Hatano;AIDS,2000

3. Incidence and risk factors of severe hypertriglyceridaemia in the era of highly active antiretroviral therapy: the Aquitaine Cohort, France, 1996-99.;Thiebaut;HIV Med,2001

4. Protease inhibitors and cardiovascular outcomes in patients with HIV-1.;Holmberg;Lancet,2002

5. HIV-associated and antiretroviral-induced hyperlipidaemia: an update.;Mauss;J HIV Ther,2003

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoparticle delivery system, highly active antiretroviral therapy, and testicular morphology: The role of stereology;Pharmacology Research & Perspectives;2021-05

2. HIV and Dyslipidemia;Contemporary Cardiology;2020-12-16

3. Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-infected patients;Journal of Antimicrobial Chemotherapy;2016-02-03

4. Antiretroviral drug-related toxicities – clinical spectrum, prevention, and management;Expert Opinion on Drug Safety;2013-06-04

5. Lipid Profiles in Young HIV-Infected Children Initiating and Changing Antiretroviral Therapy;JAIDS Journal of Acquired Immune Deficiency Syndromes;2012-08-01